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Motor Cortex
Martin V. Sale, Michael C. Ridding, andMichael A. Nordstrom
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Adelaide SA 5005, Australia
We investigatedwhether plasticity of humanmotor cortex (M1) is influenced by time of day, andwhether changes in circulating levels of
cortisol contribute to this effect. Neuroplasticitywas induced using paired associative stimulation (PAS), involving electrical stimulation
of left median nerve, paired with transcranial magnetic stimulation over the right M1 25ms later (90 pairs at 0.05 Hz). Surface EMGwas
recorded from the left abductor pollicis brevis (APB) and first dorsal interosseous muscle. Cortisol levels were assessed from saliva.
Time-of-day modulation of PAS effectiveness was assessed in 25 subjects who were tested twice, at 8:00 A.M. and 8:00 P.M. on separate
days. In a second double-blind study, 17 subjects were tested with PAS at 8:00 P.M. on two occasions after administration of oral
hydrocortisone (24 mg) or placebo. The motor-evoked potential (MEP) in resting APB increased significantly after PAS in the evening
(when endogenous cortisol levelswere low), but not in themorning.Oral hydrocortisoneprevented facilitationof theAPBMEPafter PAS,
and in thedrug study,meansalivary cortisol levelswerenegatively associatedwithPASeffectiveness. TheGABAB-mediated cortical silent
period for APB was longer in the morning than in the evening, and was lengthened by PAS and oral hydrocortisone. We conclude that
neuroplasticity in human M1 and GABAB-dependent intracortical inhibitory systems are influenced by time of day and modified by
circulating levels of cortisol.
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Introduction
Experimental techniques that induce neuroplastic changes in hu-
man motor cortex (M1) allow investigation of conditions
thought to involve aberrant neuroplasticity, including focal dys-
tonia (Quartarone et al., 2003) and Parkinson’s disease (Mor-
gante et al., 2006). Encouraging evidence suggests that induction
of M1 neuroplasticity with such techniques improves treatment
outcomes in chronic stroke patients (Uy et al., 2003; Kim et al.,
2006; McDonnell et al., 2007b). Several techniques can induce
neuroplastic changes in humans that persist for minutes to hours
after intervention, including cortical stimulation (Pascual-Leone
et al., 1994; Berardelli et al., 1998), peripheral stimulation (Rid-
ding et al., 2001; Charlton et al., 2003), and combined cortical
and peripheral nerve stimulation (Stefan et al., 2000; Ridding and
Taylor, 2001; Ridding and Flavel, 2006). The latter technique,
termed paired associative stimulation (PAS), comprises electrical
stimulation of a peripheral nerve followed by transcranial mag-
netic stimulation (TMS) of contralateral M1.With a 25ms inter-
stimulus interval between paired stimuli, 30 min of PAS induces
an increase in corticomotor excitability in the target muscle that
lasts for 30 min or more (Stefan et al., 2000). Because TMS acti-
vates pyramidal tract neurons indirectly (Day et al., 1987), and
the afferent volley from the peripheral stimulus is known to alter
corticospinal neuron excitability (Mariorenzi et al., 1991), it is
thought that the near-synchronous arrival of the two inputs with
PAS induces hebbian-like changes in synaptic efficacy, through a
long-term potentiation (LTP)-like process (Stefan et al., 2000).
The variability in responses to PAS (Fratello et al., 2006; Sale et
al., 2007) limits its usefulness for investigating pathophysiologi-
cal changes in the brain, and as an adjunct to rehabilitative ther-
apy. We recently found, inter alia, that the effectiveness and re-
producibility of PAS-induced neuroplasticity was influenced by
time of day of the PAS intervention (Sale et al., 2007), suggesting
that PAS-induced neuroplasticity may be subject to circadian
modulation. However, the experimental design did not allow di-
rect testing of this hypothesis because a different group of sub-
jects participated in themorning and afternoon experiments. The
first aim of the present study was to provide a direct test of a
time-of-day influence onM1 neuroplasticity by testing each sub-
ject with PAS at 8:00 A.M. and 8:00 P.M. on separate days.
Cortisol is a neuromodulator that could contribute to a time-
of-day variation in PAS effectiveness. Plasma cortisol concentra-
tion is highest in the morning, immediately on awakening, and
declines to reach a nadir14 h after waking (Ranjit et al., 2005).
Neuroplastic changes induced by PAS are the result of LTP-like
mechanisms, and LTP is inhibited by a cortisol metabolite in rats
(Dubrovsky et al., 1985). We measured salivary cortisol levels in
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the morning and evening to determine whether circadian
changes in endogenous cortisol levels are associated with altered
effectiveness of PAS. In a second experiment, subjects were tested
at 8:00 P.M. (low endogenous cortisol levels), and circulating
cortisol levels weremanipulated by administration of a single oral
dose of hydrocortisone (or placebo, on separate days). The results
support the hypothesis that elevated circulating cortisol levels
inhibit PAS-induced neuroplastic change in human M1.
Materials andMethods
Subjects
All subjects gave written informed consent before participation in the
study, which was approved by the University of Adelaide Human Re-
search Ethics Committee.
Experimental arrangement
Subjects were seated comfortably in an experimental chair with their left
shoulder abducted at 45° to allow the arm and hand to rest on a ma-
nipulandum. The handwas positioned such that the proximal phalanx of
the left thumb rested in a metal ring attached to a load cell. The position
of the load cell was adjusted so that it measured thumb abduction force.
Thumb abduction force was displayed on an oscilloscope in front of the
subject to provide visual feedback, and was filtered (low-pass at 50 Hz)
and digitized online (2 kHz) via a CED 1401 interface (Cambridge Elec-
tronic Design), and stored on computer for offline analysis.
Surface EMG recordings from abductor pollicis brevis (APB) and first
dorsal interosseous (FDI) muscle of the left hand were obtained using
bipolar Ag–AgCl electrodes in a belly–tendon montage. EMG signals
were amplified 1000 times, filtered (5–500 Hz), digitized online (2 kHz/
channel) via a CED 1401 interface, and stored on computer for offline
analysis. EMG signals from both muscles were displayed for the subject
on an oscilloscope to help them maintain EMG silence when required.
Maximum voluntary contractions
The abduction force exerted by the left thumb during a maximum vol-
untary contraction (MVC) was measured at the beginning of each ses-
sion. Subjects were aided in the task by visual feedback of thumb abduc-
tion force displayed on an oscilloscope. Three trials were obtained in each
sessionwith at least 30 s rest given between each trial. TheMVC force was
defined as the largest thumb abduction force observed in the three trials.
TMS and electrical stimulation of median nerve
All subjects completed a TMS safety screen (Keel et al., 2001) and were
excluded if there was a family history of epilepsy, or if they were taking
any neuroactive drugs or had undergone neurosurgery. Monophasic
TMS was applied through a figure-of-eight coil (outer diameter of each
wing, 90 mm) and a Bistim module (The Magstim Company), which
connected two Magstim 200 magnetic stimulators (The Magstim Com-
pany). This allowed the output of both machines to be directed through
the same coil. The coil was held tangentially to the skull with the handle
pointing backwards and laterally at an angle of 45° to the sagittal plane at
theoptimal scalp site toevokeamotorevokedpotential (MEP) in the relaxed
APB muscle of the left hand. With this coil placement, current flow was
induced in a posterior-to-anterior direction in the brain. The optimal scalp
positionwasmarkedwith apen, and the coilwas held throughout the exper-
iment byhand,with the position continually checked throughout the exper-
iment. Electrical stimuli were applied to themedian nerve at the wrist using
a constant current stimulator (DS7 stimulator; Digitimer) with bipolar sur-
face electrodes separated by 30mm, andwith the cathode proximal. Stimuli
were square waves with a pulse width of 200s.
PAS
ThePASprotocol used in the present study has been described previously
(Sale et al., 2007). PAS involves a series of paired peripheral and cortical
stimuli. An electrical stimulus was delivered to the median nerve of the
left wrist at an intensity sufficient to produce a small motor response in
APB (300% of perceptual threshold). The electrical stimulus was fol-
lowed 25 ms later by suprathreshold TMS over the hand area of the right
motor cortex. TMS intensity was established before PAS and produced a
MEP in resting APB of 0.5–1.0 mV (this intensity is termed SIpre). For
PAS, 90 paired peripheral and cortical stimuli were delivered at a fre-
quency of 0.05 Hz (duration 30 min).
The subject’s attentional focus is an important factor influencing PAS
effectiveness (Stefan et al., 2004). Therefore, subjects were instructed to
direct their attention onto the stimulated (left) hand during the PAS
intervention. To quantify this, subjects received intermittent weak
(200%perceptual threshold) electrical stimuli to their left thumb via ring
electrodes (Stefan et al., 2004). Between 7 and 10 stimuli were applied at
random intervals throughout the 30 min PAS session, and subjects were
instructed to count and remember the number of thumb stimuli they
received. When a thumb stimulus was delivered, it occurred at the mid-
point of the interval between successive paired stimuli in the PAS proto-
col. After the PAS protocol had concluded, subjects were asked to report
the number of stimuli delivered to the thumb. An error score was calcu-
lated, which was the difference between the number of stimuli delivered
to the thumb and the number reported by the subject.
Experiment 1: effect of time of day and endogenous cortisol levels
on PAS effectiveness
Twenty-five subjects (11 male, 14 female; aged 20–48 years; mean 27
2 years) participated in this study. Each subject was tested on two sepa-
rate occasions, once in the morning (8:00 A.M.) and once in the evening
(8 P.M.). The order of the two sessions was randomized and the sessions
were separated by at least 1 week. During the morning (A.M.) session,
PAS commenced at 8:33 A.M.  2 min, and in the evening (P.M.) ses-
sion, PAS commenced at 8:15 P.M.  2 min. Subjects had been awake
126  6 min before the commencement of PAS in the morning experi-
ments, and 766  13 min in the evening experiments. Subjects were
instructed to have a light meal before both experiments. The last meal
was consumed 98  6 min before the commencement of PAS in the
morning experiments, and 107 5 min in the evening experiments, an
insignificant difference (unpaired t test).
Single-pulse and paired-pulse TMS measures of motor
cortex excitability
Several measures of motor cortex excitability were made before and after
the PAS intervention during each experimental session (see Fig. 1A for
time line of experimental assessments).
Resting motor threshold (RMT) was defined as the minimum stimu-
lus intensity required to evoke aMEP in relaxed APB of50V in three
of five consecutive trials (Carroll et al., 2001). Active motor threshold
(AMT)was defined as theminimum stimulus intensity required to evoke
a MEP of200 V in the active (5%MVC) APB in three of five consec-
utive trials. The stimulus intensity was expressed as a percentage of max-
imum stimulator output (% MSO). RMT was assessed before and after
PAS in all experiments. AMTwas assessed before PAS only in experiment
1 (see below). All TMS pulses were delivered using the output of the
Bistim module, which reduces the output by 10% compared with a
single Magstim and leads to higher threshold values as % MSO.
Mean peak-to-peak amplitude of the APB and FDI MEP at rest was
calculated by averaging the individual peak-to-peak amplitudes ofMEPs
elicited by 20 TMS pulses (0.2 s1, SIpre) delivered immediately before
(pre-PAS), and 5 min after PAS (post-PAS).
We assessed cortical inhibition because GABAergic systems influence
LTP in rat motor cortex (Hess and Donoghue, 1994) and plasticity in
humanM1 (Butefisch et al., 2000; McDonnell et al., 2007a). The cortical
silent period (CSP) duration for APB was assessed with a TMS intensity
of 130% RMT and a contraction strength of 15% MVC. Subjects were
given visual feedback of their force level via an oscilloscope. Ten TMS
pulses were delivered at a frequency of 0.2 Hz. The duration of the APB
CSP was measured off-line from the rectified EMG traces for each trial
and averaged for the 10 trials. CSP duration was defined as the time from
TMS onset until the resumption of continuous EMG traces at prestimu-
lus levels.
Short-interval intracortical inhibition (SICI) was assessed using a pro-
tocol similar to that described previously (Kujirai et al., 1993). Paired-
pulse TMS was delivered at an interstimulus interval of 3 ms. The first
(conditioning) stimulus was subthreshold for producing aMEP in active
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APB, and activated intracortical inhibitory circuits that reduced the size
of the MEP elicited by the suprathreshold test stimulus delivered 3 ms
later. Four conditioning intensities were used: 60%, 70%, 80%, and 90%
AMT. The test stimulus intensity was set at SIpre before PAS. Because the
extent of SICImay be influenced by the size of the testMEP, the test TMS
intensity was adjusted post-PAS to match the amplitude of the test MEP
with that seen pre-PAS. This TMS intensity was termed SIpost. The effect
of conditioning TMS intensity on MEP amplitude was assessed in sepa-
rate blocks. Each block consisted of 20 trials (0.2 s1), which included 10
paired stimuli and 10 test-alone stimuli in pseudorandom order. The
order of testing blocks containing each conditioning intensity was ran-
domized. The size of the conditionedMEPwas expressed as a percentage
of the unconditioned MEP in each block to quantify the effectiveness of
SICI.
Salivary cortisol assay
Saliva samples were collected from each subject before commencement
of PAS (pre-PAS) and at the end of each experiment (post-PAS). Saliva
was frozen at20°C until assayed. On the day of assay, the saliva samples
were thawed and centrifuged. Twenty-five microliters of saliva were as-
sayed in duplicate for cortisol by ELISA (HS-Cortisol; Salimetrics).
Experiment 2: exogenous cortisol and PAS effectiveness
Seventeen subjects (8 male, 9 female, aged 19–35 years; mean 24  1
years) participated in a randomized, double-blind, placebo-controlled
study to determine whether a single oral dose of hydrocortisone modu-
lates PAS effectiveness (referred to hereinafter as the exogenous cortisol
study). One subject complained of a mild headache (hydrocortisone ses-
sion), but completed the experiment. One additional subject was tested
but withdrew because of feeling unwell (in placebo session).
Subjects were tested at 8:00 P.M. (when endogenous cortisol is low) on
two occasions separated by at least 1 week. Subjects received a gelatin-
cased capsule containing either hydrocortisone (Hysone 24 mg; Alphap-
harm) or starch (order randomized for sessions 1 and 2), which was
consumed with a glass of low-fat milk 60min before the commencement
of the experiment. Subjects were instructed to fast for 3 h before the
commencement of the experiment. The last meal was consumed 195
18 min before the commencement of PAS in the placebo experiments,
and 199 41min in the cortisol experiments, an insignificant difference
(unpaired t test). PAS commenced at 8:09 P.M. 2 min in the placebo
session and 8:08 P.M. 1 min in the cortisol session. Subjects had been
awake for 738 27 min in the placebo session,
and 737  32 min in the cortisol session, an
insignificant difference (unpaired t test). Saliva
samples were taken before ingestion of medica-
tion (pre-ingestion), before PAS (pre-PAS), and
after PAS (post-PAS), and later assayed for sali-
vary cortisol concentration.
The experimental procedures and protocol
for the exogenous cortisol study were as for ex-
periment 1, except that AMT and SICI were not
assessed (see Fig. 1B for time line of experimen-
tal procedures).
Statistical analysis
Experiment 1. Three-way repeated-measures
ANOVA was performed on MEP amplitude
data fromAPB and FDIwith within-subject fac-
tors intervention (two levels: pre-PAS and post-
PAS), time of day (two levels: A.M. and P.M.),
and between-subject factor gender (two levels:
male and female) to determine the effect of PAS
and time of day on the extent of MEP facilita-
tion. Two-way repeated-measures ANOVA as-
sessed the effect of intervention and time of day
on APB resting motor threshold and cortical si-
lent period. One-way repeated-measures
ANOVA assessed the effect of time of day on
APB active motor threshold. Three-way
repeated-measures ANOVA with within-
subject factors of intervention, time of day, and
conditioning intensity (four levels: 60% AMT, 70% AMT, 80% AMT,
and 90% AMT) assessed the effect of these factors on SICI.
Experiment 2. Three-way repeated-measures ANOVA was performed
on MEP amplitude data from APB and FDI with within-subject factors
intervention (two levels: pre-PAS and post-PAS) and medication (two
levels: hydrocortisone and placebo), and gender (two levels: male and
female) to determine the effect of PAS and medication on the extent of
MEP facilitation. Two-way repeated-measures ANOVA assessed the ef-
fect of intervention andmedication on APB resting motor threshold and
cortical silent period.
Linear regression analysis was used on data from experiments 1 and 2
to examine the relationship between salivary cortisol concentration and
both APB MEP facilitation (post-PAS MEP amplitude/pre-PAS MEP
amplitude) and the pre-PAS cortical silent period duration. The salivary
cortisol concentration data were log-transformed to improve homosche-
dasticity. The strength of the relationship was quantified by the coeffi-
cient of determination (r 2).
For all analyses, p  0.05 was chosen as the significance level, and
unless stated otherwise, all group data are reported as mean  SEM.
Fisher’s PLSD post hoc tests were performed as appropriate.
Results
Experiment 1: effect of time of day and endogenous cortisol
levels on PAS effectiveness
TMS intensity used during PAS (SIpre) was not significantly dif-
ferent in the endogenous cortisol experiments between the
morning and evening sessions (76 3%MSO vs 74 3%MSO,
respectively), corresponding to 127 3%RMT versus 127 3%
RMT. Intensity of peripheral nerve stimulation during PAS was
6.5 0.5 mA for the morning session and 5.8 0.5 mA for the
evening session, an insignificant difference (unpaired t test).
ANOVA revealed no effect of time of day (F(1,24)  2.14) or
intervention (F(1,24)  1.65) on resting motor threshold in the
endogenous cortisol experiments. In the morning, RMT was
60  2% MSO pre-PAS and 59  2% MSO post-PAS. In the
evening, RMT was 59  2% MSO pre-PAS and 57  3% MSO
post-PAS. There was also no significant effect of time of day on
active motor threshold (F(1,24)  3.14). AMT was only assessed
Figure 1. A, B, Schematic diagram of the testing protocol indicating the approximate relative timings for assessment of
neurophysiological parameters before and after PAS in experiment 1 (A) and experiment 2 (B). The gray bars indicatewhen saliva
samples were collected. Measurements of APBMEP amplitude were made at two time points: pre-PAS and post-PAS. Ingestion,
Oral dose of hydrocortisone or placebo.
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before PAS. In the morning AMT was 48 2% MSO and in the
evening, 46 2%MSO.
The extent of MEP facilitation induced in APB by PAS was
larger in the evening sessions than in the morning, and this effect
was consistent across gender (F(1,23) 0.40); thus, the data were
pooled for males and females. The group data on PAS effective-
ness for the 25 subjects are summarized in Figure 2. On average,
APB MEP amplitude increased by 15% in morning experiments
and by 41% in evening experiments (Fig. 2A). There was a signif-
icant effect of time of day (F(1,24)  7.67, p  0.011) and inter-
vention (F(1,24) 9.84, p 0.005) onAPBMEPamplitude. There
was also a time of day intervention interaction (F(1,24) 4.45,
p  0.045), indicating that the effectiveness of PAS was influ-
enced by the time of day. Post hoc analysis revealed that there was
significant APB MEP facilitation in the evening (Fisher, p 
0.001), whereas there was no significant change in APB MEP
amplitude after PAS in the morning (Fisher). APB MEP ampli-
tude before PAS was not significantly different between sessions
(A.M., 0.76  0.07 mV; P.M., 0.78  0.06 mV). APB MEP am-
plitude after PAS (post-PAS) was significantly greater in the
evening compared with the morning ( p  0.001) (Fig. 2A). As
expected, PAS did not result in significant facilitation of MEPs
evoked in the FDI muscle (intervention, F(1,24) 0.95). The FDI
MEP was 3% smaller after PAS in the morning, and 16% larger
after PAS in the evening (Fig. 2B). There was no significant effect
of time of day on FDI MEP amplitude (F(1,24) 0.76).
Time of day did not influence attention-related error scores,
indicating that the subjects were attending to the task equally well
in the morning and evening experiments. The mean error score
in the morning session was 0.24  0.10 and in the evening ses-
sion, 0.28 0.09 (F(1,24) 0.07).
Cortical silent period data from experiment 1 are summarized
in Figure 3. Both time of day (F(1,24)  9.04, p  0.006) and
intervention (F(1,24) 27.47, p 0.001) influenced cortical silent
period duration. The interaction term was not significant (F(1,24)
 0.28), indicating that PAS had similar effects on the cortical
silent period inmorning and evening experiments. Cortical silent
period duration was significantly shorter in the evening (pre-
PAS, 183 5 ms) compared with the morning (pre-PAS, 193
7ms) ( p 0.016), and the duration of the silent period increased
by6% after PAS (pre-PAS, 188 4ms vs post-PAS 199 4ms;
p 0.002).
PAS did not significantly alter SICI (intervention, F(1,72) 
0.30; see Fig. 4), and the overall effectiveness of SICI was similar
in the morning and evening (time of day, F(1,72)  1.29). As
expected, SICI was a function of conditioning TMS intensity
(F(3,72) 25.76, p 0.001). Post hoc analysis revealed that MEP
suppression with a conditioning intensity of 60% AMT was sig-
nificantly less thanMEP suppression using all other conditioning
intensities (Fisher, p 0.001), and that MEP suppression with a
conditioning intensity of 70% AMT was significantly less than
MEP suppression using conditioning intensities of 80% AMT
and 90% AMT (Fisher, p  0.001). Conditioning at 60% AMT
did not suppress the MEP (paired t test), whereas higher condi-
tioning intensities produced significant inhibition of the MEP
Figure 2. A, B, Group (mean SEM) MEP amplitude for APB (A) and FDI (B) before (pre-
PAS) and after (post-PAS) paired associative stimulation. Data are from morning experiments
(am) on the left, and evening (pm) experiments on the right. APB MEP amplitude was signifi-
cantly larger post-PAS than pre-PAS in the evening session (*p 0.001), but not in themorn-
ing. APBMEP amplitude post-PASwas significantly greater in the evening than in themorning
( #p 0.001). FDI MEP amplitude (B) was not affected by PAS or time of day.
Figure 3. Group (mean SEM) data of cortical silent period duration before (pre-PAS) and
after (post-PAS)pairedassociative stimulation.Data frommorningexperiments (am)areon the
left, and evening (pm) experiments are on the right. Cortical silent period duration was signif-
icantly longer in themorning (*p0.006) than in the evening. Therewas a significant increase
in cortical silent period duration after PAS in both the morning and evening sessions (#p
0.002).
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(paired t tests, p  0.001). The APB MEP amplitude in single-
pulse trials did not differ pre- and post-PAS (intervention, F(1,72)
 4.17), because of a small reduction of test TMS intensity post-
PAS (76%MSOpre-PAS vs 74%MSOpost-PAS). There was also
no significant effect of time of day (F(1,72)  0.01) on MEP am-
plitude in single-pulse trials. This indicates that test MEP ampli-
tudes were well matched throughout the assessment of SICI.
Experiment 2: Exogenous cortisol and PAS effectiveness
TMS intensity used during PAS (SIpre) was not significantly dif-
ferent between the placebo and cortisol sessions (75 3%MSO
vs 75  3% MSO, respectively), corresponding to 123  2%
RMT versus 123  3% RMT. The intensity of peripheral nerve
stimulation during PAS was 6.7 0.6 mA for the placebo session
and 6.5 0.5 mA for the cortisol session, an insignificant differ-
ence (unpaired t test).
ANOVA revealed no significant effect ofmedication (F(1,16)
0.48) or intervention (F(1,16) 0.01) on resting motor threshold.
In the placebo session, RMT was 61  2% MSO pre-PAS and
61 2%MSO post-PAS. In the cortisol session, RMT was 61
2%MSO pre-PAS and 60 2%MSO post-PAS.
There was significant facilitation of APBMEP amplitude after
PAS in the placebo session, but not in the session when subjects
received oral hydrocortisone (Fig. 5A). This effect was consistent
across gender (F(1,15)  0.21), and thus data were pooled for
males and females. Two-way repeated-measures ANOVA indi-
cated no significant effect of medication (F(1,16) 0.64) or inter-
vention (F(1,16) 3.28), but there was a significant medication
intervention interaction (F(1,16)  9.78, p  0.007), indicating
that the effect of PAS onMEP amplitude was influenced bymed-
ication. APB MEP amplitude increased significantly by 28% in
the placebo session after PAS (Fisher, p  0.039), yet with oral
hydrocortisone, APB MEP amplitude de-
creased (non-significantly) by 6% (Fisher).
FDI MEP amplitude (Fig. 5B) was not in-
fluenced by medication (F(1,16)  3.77) or
intervention (F(1,16) 1.98), and the inter-
action term was not significant (F(1,16) 
0.35).
Cortical silent period data from experi-
ment 2 are summarized in Figure 6. Both
medication (F(1,16) 5.16, p 0.037) and
intervention (F(1,16)  216.37, p  0.001)
influenced cortical silent period duration.
The interaction term was not significant
(F(1,16)  2.28), indicating that PAS had
similar effects on the cortical silent period
in hydrocortisone and placebo sessions.
Cortical silent period duration was signifi-
cantly shorter in the placebo (pre-PAS,
193 5 ms) compared with the hydrocor-
tisone session (pre-PAS, 206 3ms) ( p
0.001), and the duration of the silent pe-
riod increased by 10% after PAS (pre-
PAS, 199  3 ms vs post-PAS 218  3 ms
( p 0.001).
Salivary cortisol levels and relationships
with PAS effectiveness and cortical
silent period
Saliva samples obtained during the experi-
ments were assayed for salivary cortisol
concentration. For experiment 1, saliva
samples were taken before (pre-PAS) and after PAS (post-PAS).
There was a significant effect of time of day (F(1,24) 86.90, p
0.001) and intervention (F(1,24)  10.72, p  0.003) on salivary
cortisol concentration (Fig. 7A). There was also a significant in-
teraction of time of day intervention (F(1,24) 5.57, p 0.027).
Post hoc analysis revealed that salivary cortisol concentration be-
fore PAS in themorning sessionwas higher than at all other times
of saliva sampling ( p  0.001). Salivary cortisol concentration
after PAS (post-PAS) in the morning session was greater than
salivary cortisol concentration in the evening sessions ( p 
0.001) (Fig. 7A).
For experiment 2, saliva samples were taken before ingestion
of themedication (pre-ingestion) as well as before (pre-PAS) and
after PAS (post-PAS). There was a significant effect of time (three
levels: pre-ingestion, pre-PAS, post-PAS) (F(2,32)  5.07, p 
0.012) and medication (F(1,32)  11.46, p  0.004) on salivary
cortisol levels (Fig. 7B). There was also a significant timemed-
ication (F(1,32)  4.78, p  0.015) interaction. Post hoc analysis
revealed that oral hydrocortisone administration elevated sali-
vary cortisol levels, with both pre-PAS and post-PAS cortisol
concentrations significantly higher than pre-ingestion levels
( p 0.001). There was no significant difference in salivary cor-
tisol concentration during the placebo experiments.
Because salivary cortisol concentration changed over the time
it took to deliver PAS (Fig. 7A), the pre-PAS and post-PAS sali-
vary cortisol concentrationswere averaged to provide a value that
reflects the mean circulating cortisol level during PAS. This was
used in the linear regression analysis of the association between
salivary cortisol level and MEP facilitation induced by PAS (Fig.
7C,D), and cortical silent period duration (Fig. 7E,F). For exper-
iment 1, there was no significant relationship between the (log)
average salivary cortisol concentration and the extent of APB
Figure 4. Influence of PAS and time of day on SICI. Group (mean SEM) SICI data from 20 subjects assessed in the morning
(am; circles) and evening (pm; triangles), before (pre-PAS; filled symbols) and after (post-PAS; open symbols) paired associative
stimulation. SICI was assessed with paired-pulse TMS using four different conditioning TMS intensities (60–90% AMT), with an
interstimulus interval of 3ms. SICI was quantified as percentage of MEP amplitude obtained in conditioned trials comparedwith
test-alone trials. SICI was unchanged after PAS both in the A.M. and P.M.. The overall level of SICI did not differ between A.M. and
P.M. sessions.
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MEP facilitation (r2  0.04) (Fig. 7C). In contrast, with exoge-
nous cortisol administration in experiment 2, there was a weak
but significant negative relationship between the average salivary
cortisol concentration and the extent of APB MEP facilitation
after PAS (r2  0.13, p  0.039) (Fig. 7D). There was greater
facilitation of the APBMEP after PAS when salivary cortisol con-
centration was low. There was no significant relationship be-
tween average salivary cortisol concentration and pre-PAS corti-
cal silent period duration in experiment 1 (r2 0.002) (Fig. 7E).
However, in experiment 2, there was a significant positive rela-
tionship between salivary cortisol concentration and pre-PAS
cortical silent period duration (r2  0.14, p  0.028) (Fig. 7F).
There was no significant relationship between the pre-PAS CSP
values and MEP facilitation ratio for either experiment 1 (r2 
0.02, n  50) or experiment 2 (r2  0.08, n  34) (data not
shown).
Discussion
The principal novel findings from this study are that MEP facili-
tation after PAS was influenced by time of day and oral hydro-
cortisone administration. There was significant MEP facilitation
in the target muscle after PAS in the evening. However, during
periods of high circulating cortisol levels (in the morning or with
oral hydrocortisone in the evening), therewas no significantMEP
facilitation. Additionally, the time of day, PAS, and circulating
cortisol levels influenced CSP duration.
M1 neuroplasticity is influenced by time of day
We recently reported that PAS wasmore effective in experiments
conducted in the afternoon than in the morning (Sale et al.,
2007); however, different subjects were tested at those times. The
present study extends that result by showing, in the same groupof
subjects, that PAS effectiveness is greater in the evening than in
the morning.
PAS induces M1 plasticity by LTP-like mechanisms (Stefan et
al., 2000, 2002; Wolters et al., 2003, Ziemann et al., 2004). M1 is
considered the primary site of corticomotor excitability change
induced by PAS (Stefan et al., 2000;Wolters et al., 2003;Mu¨ller et
al., 2007), butwe have not excluded effects on remote sites such as
spinal cord or ipsilateral primary sensory cortex (Murakami et
al., 2008). PAS-induced changes in spinal excitability have been
reported (Meunier et al., 2007), although others find no change
(Stefan et al., 2000; Wolters et al., 2003).
It has been proposed that wakefulness favors LTP-like pro-
cesses and leads to net synaptic potentiation, whereas sleep favors
LTD-like processes and leads to homeostatic synaptic depression
(Tononi and Cirelli, 2006). According to this theory, prolonged
wakefulness should make induction of LTP-like plasticity more
difficult, because LTP can be saturated by previous LTP-like
learning (Rioult-Pedotti et al., 2000; Whitlock et al., 2006). LTP
in rat cerebral cortex is inducedmore readily 1–60min after sleep
than after several hours of wakefulness (Vyazovskiy et al., 2008).
In contrast, we found PAS more effective in the evening, when
subjects had been awake 766 13min, comparedwith themorn-
ing when they had been awake 126 6 min. The reasons for this
Figure 5. A, B, Group (mean SEM) MEP amplitude for APB (A) and FDI (B) before (pre-
PAS) and after (post-PAS) paired associative stimulation. Data from the hydrocortisone (corti-
sol) administration session are on the left, and data from the placebo session are on the right.
APB MEP amplitude was significantly larger post-PAS than pre-PAS in the placebo session
(*p 0.007), but not in the cortisol session. APB MEP amplitude post-PAS was significantly
greater in the placebo than in the cortisol session ( #p 0.039). FDIMEP amplitude (B) was not
affected by PAS or medication.
Figure 6. Group (mean SEM) data of cortical silent period duration before (pre-PAS) and
after (post-PAS) paired associative stimulation. Data from the hydrocortisone (cortisol) admin-
istration group are on the left, and data from the placebo group are on the right. Cortical silent
period durationwas significantly longer in the cortisol (*p 0.001) than in the placebo group.
There was a significant increase in cortical silent period duration after PAS in both sessions
(#p 0.001).
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discrepancy are not clear, but our results suggest that other fac-
tors, such as cortisol levels, influence LTP-like neuroplasticity.
Cortisol andM1 neuroplasticity
Time-of-day modulation of PAS effectiveness may be due to cir-
cadian changes in neuromodulators. LTP in hippocampus exhib-
its a circadian rhythm (Raghavan et al., 1999; Chaudhury et al.,
2005). Cortisol is a candidate neuromodulator because it has a
circadian rhythm, and a corticosterone
metabolite impairs LTP in rat hippocam-
pus (Dubrovsky et al., 1985). Acute (New-
comer et al., 1999; deQuervain et al., 2000)
and chronic (Starkman et al., 1992) eleva-
tion of plasma cortisol have been associ-
ated withmemory impairment in humans.
Plasma cortisol concentration rises
quickly after awakening in the morning,
and is low during the afternoon and
evening (Ranjit et al., 2005). PAS effective-
ness is enhanced in the evening (Fig. 2)
when endogenous cortisol is low. Effects of
PAS in the evening are blocked by a single
oral dose of hydrocortisone (Fig. 5), which
is metabolized to cortisol in the body.
Cortisol has wide-ranging effects on
physiological processes, and we are unable
to determine whether impairment of neu-
roplasticity by hydrocortisone is mediated
directly by cortisol or indirectly by effects
on other neuromodulator(s). Cortisol may
also delay the time course of PAS effects,
rather than reducing them. Future studies
could address this by assessing MEP facili-
tation at multiple time points after PAS.
Cortisol is rapidly metabolized on re-
lease (Edwards et al., 2001), and fluctua-
tions in cortisol levels during experiment 1
(Fig. 7A) may contribute to the lack of as-
sociation between salivary cortisol levels
and PAS effectiveness. Higher levels of cor-
tisol in experiment 2 (Fig. 7B)may bemore
effective in suppressing neuroplasticity
and contribute to the significant negative
association between salivary cortisol and
neuroplasticity in experiment 2. A single
oral dose of hydrocortisone impairs learn-
ing and memory in humans (de Quervain
et al., 2000; Hsu et al., 2003), and salivary
cortisol levels in experiment 2 are in the
range reported by de Quervain et al.
(2000).
Although circulating cortisol levels ap-
pear to influence PAS-induced neuroplas-
ticity, the weak correlation between these
variables indicates a contribution from
other factors. Because experiment 1 was
performed at two different times of day,
circadian modulation of other (non-
measured) neuromodulators may have in-
fluenced results, including dopamine
(Castan˜eda et al., 2004) and melatonin
(Collins and Davies, 1997; El-Sherif et al.,
2003), both of which influence LTP (Col-
lins and Davies, 1997; Kusuki et al., 1997; El-Sherif et al., 2003).
Because both sessions of experiment 2 were in the evening,
between-session circadian variation in other neuromodulators
would have less influence on PAS effectiveness in experiment 2
than in experiment 1.
Subjects participated in two experimental sessions separated
by at least 1 week. Between-session changes in factors known to
modulate cortical excitability, including physical activity (Cot-
Figure7. A–F, Salivary cortisol concentration (A,B) and the relationshipbetween salivary cortisol concentrationandAPBMEP
facilitation after PAS (C,D) and cortical silent period duration (E, F ). Data from study 1 (endogenous cortisol) are on the left, and
data from study 2 (hydrocortisone administration) are on the right. Pre-PAS salivary cortisol concentration in the morning was
significantly greater than all other samples (A) (*p  0.001). Post-PAS salivary cortisol concentration in the morning was
significantly greater than both P.M. samples, but less than the pre-PAS A.M. sample ( #p  0.001). B, Exogenous cortisol
administration significantly elevated salivary cortisol concentration in the evening compared with placebo (*p 0.001). C,
Linear regression analysis revealed a nonsignificant relationship (r 2 0.04) between the log of average salivary cortisol con-
centration andAPBMEP facilitation ratio (post-PASMEP amplitude/pre-PASMEP amplitude) in study 1 (endogenous cortisol).D,
Linear regression analysis revealed a significant negative relationship (r 20.13,p0.039) between the logof average salivary
cortisol concentration andAPBMEP facilitation ratio in study 2 (hydrocortisone administration).E, Nonsignificant relationship (r 2
 0.002) between the log of average salivary cortisol concentration and pre-PAS cortical silent period duration in study 1. F,
Significant relationship (r 2 0.14, p 0.028) between the log of average salivary cortisol concentration and pre-PAS cortical
silent period duration in study 2.
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man and Engesser-Cesar, 2002), may have influenced the results.
Changes in menstrual cycle hormones also influence cortical ex-
citability (Smith et al., 1999); however, we found no gender dif-
ferences in PAS-induced neuroplasticity. Menopausal women
aged50 years are less responsive to PAS according to Tecchio et
al. (2008); however, that study reported no differences between
young men and women, consistent with the present study.
Modulation of intracortical inhibition
GABAergic inhibitory tonemodulates LTP-like plasticity, andwe
considered whether changes in M1 inhibitory tone influenced
PAS effectiveness. Downregulation of GABAA-mediated inhibi-
tion promotes LTP induction in ratmotor cortex slices (Hess and
Donoghue, 1994) and PAS-induced neuroplasticity in human
M1 (Butefisch et al., 2000). Additionally, the GABAB receptor
agonist baclofen suppresses LTP-like plasticity in human M1
(McDonnell et al., 2007a). GABAB inhibitory tone in M1, as as-
sessed by CSP, was higher in morning sessions and with evening
hydrocortisone administration. This is when PAS was less effec-
tive, suggesting that GABAB inhibitory tone may modulate PAS
effectiveness, consistent with findings obtained with baclofen
(McDonnell et al., 2007a). However, the absence of a significant
relationship between pre-PASCSPduration andMEP facilitation
ratio in experiment 1 and experiment 2 argues against a direct
effect of physiological variation inGABAB inhibitory tone onPAS
effectiveness.
A prolonged CSP after PAS confirms previous results (Stefan
et al., 2000; Quartarone et al., 2003; Sale et al., 2007). The CSP is
believed to have both a spinal and a cortical (GABAB receptor-
mediated) component (Werhahn et al., 1999). Spinal mecha-
nisms contribute to EMG suppression in the first part of the silent
period (100ms), asH-reflexes are suppressed (Fuhr et al., 1991;
Uncini et al., 1993). The later part of the CSP, whenmotoneuron
excitability is at pre-stimulus levels, is attributed to cortical in-
hibitory mechanisms (Inghilleri et al., 1993; Chen et al., 1999).
The increase in CSP duration after PAS and with high cortisol
levels (Figs. 3, 5) is therefore most likely the result of changes in
cortical inhibition. CSPdurationwas increased after PAS, regard-
less of whether the MEP was facilitated. This is not surprising
because the inhibitory processes responsible for the CSP are rel-
atively independent of the extent of activation of corticospinal
descending projection tomotoneurons by TMS (Ho et al., 1998),
and the CSP was assessed during voluntary activation, whereas
PAS-induced MEP facilitation was assessed at rest.
SICI is believed to reflect GABAA inhibition (Ilic´ et al., 2002;
Ziemann, 2003). There was no change in SICI after PAS, which
supports previous findings (Ridding and Taylor, 2001; Stefan et
al., 2002;Quartarone et al., 2003; Kujirai et al., 2006). Kujirai et al.
(2006) found reduced SICI after PAS using a coil orientation that
preferentially activated late I-waves, which are more susceptible
to intracortical inhibition (Nakamura et al., 1997; Di Lazzaro et
al., 1998; Hanajima et al., 1998). Therefore, it is possible that PAS
may produce subtle changes in SICI not detected with the coil
orientation we used.
SICI was not influenced by time of day (or cortisol levels) in
experiment 1 and does not appear tomodulate PAS effectiveness.
Circadian variation in GABA release has been demonstrated in
the mammalian brain (Castan˜eda et al., 2004; Gompf and Allen,
2004), and GABAA-induced chloride currents are enhanced by
metabolites of steroid hormones (Majewska et al., 1986). Our
assessment of SICI may not be sufficiently sensitive to detect
small time-of-day changes in SICI (see above). Alternatively, per-
haps there is little modulation of GABA release (after PAS or at
different times of day) onto GABAA receptors in theM1 circuitry
acted on by paired-pulse TMS.
In conclusion, neuroplasticity induction in human M1 with
PASwasmore effective in the evening, when endogenous cortisol
levels were low. Hydrocortisone administration in the evening
raised circulating cortisol levels and impaired M1 neuroplastic-
ity. PAS-induced LTP-like plasticity engages neural circuits in-
volved inmotor learning in humans (Ziemann et al., 2004; Stefan
et al., 2006). Our findings have important implications for reha-
bilitative therapies using neuroplastic change in human M1 to
promote functional recovery (Uy et al., 2003; Kim et al., 2006;
McDonnell et al., 2007b), because they suggest that plasticity
induction and, presumably, any therapeutic benefit would be
enhanced when circulating cortisol levels are low.
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